TVTX•benzinga•
Travere Submits sNDA To FDA For Seeking Priority Review For Traditional Approval Of FILSPARI For Focal Segmental Glomerulosclerosis Treatment
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 17, 2025 by benzinga